The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding atrial fibrillation .
Blog
Many medical device manufacturers have found themselves caught in a trap where there is a DRG and/or ZE (add-on payment) available for their technology but where the insurance companies refuse to pay this fee.
Background
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding rheumatoid arthritis .
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding stroke.
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding MS.
In our journey to create insight in the utility, we have made a search for registry based randomized clinical trials. Below is a summary of what we have identified so far.
This is a summary of the pilot study regarding the development of a value-based monitoring platform for stroke care in Sweden.
Initial analysis of data
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding diabetes.
This is a summary of the pilot study regarding the development of a value-based monitoring platform for diabetes care in Sweden.
Initial analysis of data

